Richard Kremer

Kremer later moved to Canada where he completed further residency training in Endocrinology and Laboratory Medicine at the Montreal General, Royal Victoria, and Ottawa Civic Hospitals.

[1] Kremer was credited for creating the antibodies that blocked the Parathyroid Hormone-Related Protein (PTHrP) in a widely reported study on Pancreatic Cancer.

[5] Kremer previously discovered PTHrP's initiating role in Breast Cancer and its progression which could also be blocked by anti-PTHrP antibodies as was reported in 2011.

[8] Kremer and colleagues reported that women who use oral bisphosphonates to prevent osteoporosis may also be at lower risk of skeletal complications of breast cancer.

[14] On a similar line of inquiry, earlier studies by Kremer and colleagues demonstrated the link between a lack of vitamin D and weight gain and stunted growth in girls.